Browse

You are looking at 1 - 10 of 12 items

Mauro Boronat Section of Endocrinology and Nutrition, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain
Research Institute in Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain

Search for other papers by Mauro Boronat in
Google Scholar
PubMed
Close

Summary

Isolated, adult-onset central hypothyroidism is very rare, and its diagnosis can be challenging. A 42-year-old patient was referred for evaluation of a 2.8 cm thyroid nodule. She referred symptoms that could be attributed to hypothyroidism and thyroid tests showed low TSH and normal-low levels of free T4. However, evaluation of the remaining pituitary hormones and pituitary MRI were normal, yet a radionuclide scanning revealed that the thyroid nodule was ‘hot’ and the tracer uptake in the remaining thyroid tissue was suppressed. Interpretation of these studies led to a misdiagnosis of subclinical hyperthyroidism and the patient was treated with radioiodine. Soon after treatment, she developed a frank hypothyroidism without appropriate elevation of TSH and the diagnosis of central hypothyroidism was made a posteriori. Long term follow-up revealed a progressive pituitary failure, with subsequent deficiency of ACTH and GH. This case should alert to the possibility of overlooking central hypothyroidism in patients simultaneously bearing primary thyroid diseases able to cause subclinical hyperthyroidism.

Learning points:

  • Although rarely, acquired central hypothyroidism can occur in the absence of other pituitary hormone deficiencies.

  • In these cases, diagnosis is challenging, as symptoms are unspecific and usually mild, and laboratory findings are variable, including low, normal or even slightly elevated TSH levels, along with low or low-normal concentrations of free T4.

  • In cases with low TSH levels, the coexistence of otherwise common disorders able to cause primary thyroid hyperfunction, such as autonomous nodular disease, may lead to a misdiagnosis of subclinical hyperthyroidism.

Open access
Shanika Samarasinghe Division of Endocrinology and Metabolism, Loyola University Medical Center, Maywood, Illinois, USA

Search for other papers by Shanika Samarasinghe in
Google Scholar
PubMed
Close
,
Simge Yuksel Division of Internal Medicine, Loyola University Medical Center, Maywood, Illinois, USA

Search for other papers by Simge Yuksel in
Google Scholar
PubMed
Close
, and
Swati Mehrotra Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, Illinois, USA

Search for other papers by Swati Mehrotra in
Google Scholar
PubMed
Close

Summary

We report a rare case of concurrent medullary thyroid cancer (MTC) and papillary thyroid cancer (PTC) with intermixed disease in several of the lymph node (LN) metastases in a patient who was subsequently diagnosed with clear cell renal cell carcinoma (RCC). A 56 year old female presented with dysphagia and was found to have a left thyroid nodule and left superior cervical LN with suspicious sonographic features. Fine needle aspiration biopsy (FNAB) demonstrated PTC in the left thyroid nodule and MTC in the left cervical LN. Histopathology demonstrated multifocal PTC with 3/21 LNs positive for metastatic PTC. One LN in the left lateral neck dissection exhibited features of both MTC and PTC within the same node. In the right lobe, a 0.3 cm focus of MTC with extra-thyroidal extension was noted. Given persistent calcitonin elevation, a follow-up ultrasound displayed an abnormal left level 4 LN. FNAB showed features of both PTC and MTC on the cytopathology itself. The patient underwent repeat central and left radical neck dissection with 3/6 LNs positive for PTC in the central neck and 2/6 LNs positive for intermixed PTC and MTC in the left neck. There was no evidence of distant metastases on computed tomography and whole body scintigraphy, however a 1.9 x 2.5 cm enhancing mass within the right inter-polar kidney was discovered. This lesion was highly suspicious for RCC. Surgical pathology revealed a 2.5 cm clear cell RCC, Fuhrman grade 2/4, with negative surgical margins. She continues to be observed with stable imaging of her triple malignancies.

Learning points:

  • Mixed medullary-papillary thyroid neoplasm is characterized by the presence of morphological and immunohistochemical features of both medullary and papillary thyroid cancers within the same lesion. Simultaneous occurrence of these carcinomas has been previously reported, but a mixed disease within the same lymph node is an infrequent phenomenon.

  • Prognosis of mixed medullary-papillary thyroid carcinomas is determined by the medullary component. Therefore, when PTC and MTC occur concurrently, the priority should be given to the management of MTC, which involves total thyroidectomy and central lymph node dissection.

  • Patients with thyroid cancer, predominantly PTC, have shown higher than expected rates of RCC. To our knowledge, this is the first report describing the combination of MTC, PTC, and RCC in a single patient.

Open access
Alexa Clark Department of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Alexa Clark in
Google Scholar
PubMed
Close
,
Marosh Manduch Department of Pathology and Molecular Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Marosh Manduch in
Google Scholar
PubMed
Close
,
Russell Hollins Department of Otolaryngology, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Russell Hollins in
Google Scholar
PubMed
Close
, and
Sara Awad Division of Endocrinology and Metabolism, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Sara Awad in
Google Scholar
PubMed
Close

Summary

We report a case of metastatic papillary thyroid carcinoma presenting with a recurrent right-sided cervical lymph node necrotic cyst. A 55-year-old woman presented with a 3-month history of a right-sided upper neck mass following an upper respiratory tract infection. Past medical history includes a right-sided nephrectomy secondary to a benign renal tumor and hypertension. She was evaluated by Otolaryngology, and fine-needle aspiration was performed. The mass recurred 2 months following aspiration. Ultrasound of the neck showed a 2.2 × 1.4 × 1.9 cm right cervical lymph node with a small fatty hilum but a thickened cortex. Neck computed tomography (CT) scan showed a well-defined 2.3 cm mass in the right upper neck corresponding to a necrotic cervical lymph node at level IIA. It also revealed a 7 mm calcified left thyroid nodule. Cytology revealed a moderate collection of murky fluid with mildly atypical cells presumed to be reactive given the clinical history of infection. The cyst had re-grown 2 months following aspiration. Excisional biopsy was performed and revealed metastatic classic papillary thyroid carcinoma (PTC). Subsequently, a total thyroidectomy and right neck dissection was performed. Pathology confirmed metastatic unifocal classic PTC of the right thyroid lobe and two lymph node metastases out of a total of 17 resected lymph nodes. The patient underwent radioactive iodine ablation. Subsequent I-131 radioiodine whole-body scan showed no evidence of metastases. In conclusion, metastatic PTC should be considered in the differential diagnosis of a recurrent solitary cystic cervical lymph node.

Learning points:

  • Metastatic PTC should be considered in the differential diagnosis of a recurrent solitary cystic cervical lymph node.

  • A dedicated thyroid ultrasound is the preferred modality for identifying thyroid lesion over computed tomography.

  • There is a risk of non-diagnostic cytology following FNA for cystic neck lesions, largely predicted by the cyst content of the nodule.

Open access
Jill Pancer Division of Endocrinology, McGill University Health Centre, Montreal, Quebec, Canada

Search for other papers by Jill Pancer in
Google Scholar
PubMed
Close
,
Elliot Mitmaker Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada

Search for other papers by Elliot Mitmaker in
Google Scholar
PubMed
Close
,
Oluyomi Ajise Department of Pathology, McGill University Health Centre, Montreal, Quebec, Canada

Search for other papers by Oluyomi Ajise in
Google Scholar
PubMed
Close
,
Roger Tabah Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada

Search for other papers by Roger Tabah in
Google Scholar
PubMed
Close
, and
Jacques How Division of Endocrinology, McGill University Health Centre, Montreal, Quebec, Canada

Search for other papers by Jacques How in
Google Scholar
PubMed
Close

Summary

Multifocal papillary thyroid carcinoma (PTC) is common and the number of tumor foci rarely exceeds ten. The mechanism of multifocal disease is debated, with the two main hypotheses consisting of either intrathyroidal metastatic spread from a single tumor or independent multicentric tumorigenesis from distinct progenitor cells. We report the case of a 46-year-old woman who underwent total thyroidectomy and left central neck lymph node dissection after fine-needle aspiration of bilateral thyroid nodules that yielded cytological findings consistent with PTC. Final pathology of the surgical specimen showed an isthmic dominant 1.5 cm classical PTC and over 30 foci of microcarcinoma, which displayed decreasing density with increasing distance from the central lesion. Furthermore, all malignant tumors and lymph nodes harbored the activating BRAF V600E mutation. The present case highlights various pathological features that support a mechanism of intraglandular spread, namely a strategic isthmic location of the primary tumor, radial pattern of distribution and extensive number of small malignant foci and BRAF mutational homogeneity.

Learning points:

  • Multifocal papillary thyroid carcinoma (PTC) is commonly seen in clinical practice, but the number of malignant foci is usually limited to ten or less.

  • There is no clear consensus in the literature as to whether multifocal PTC arises from a single or multiple distinct tumor progenitor cells.

  • Strategic location of the dominant tumor in the thyroid isthmus may favor intraglandular dissemination of malignant cells by means of the extensive lymphatic network.

  • An important pathological finding that may be suggestive of intrathyroidal metastatic spread is a central pattern of distribution with a reduction in the density of satellite lesions with increasing distance from the dominant focus.

  • PTCs originating from the isthmus with intraglandular metastatic dissemination behave more aggressively. As such, a more aggressive treatment course may be warranted, particularly with regard to the extent of surgery.

Open access
Laura Hamilton Adams Department of Endocrinology, Diabetes, and Metabolism, University of Kentucky, Lexington, Kentucky, USA

Search for other papers by Laura Hamilton Adams in
Google Scholar
PubMed
Close
and
Derick Adams Department of Endocrinology, Diabetes, and Metabolism, University of Kentucky, Lexington, Kentucky, USA

Search for other papers by Derick Adams in
Google Scholar
PubMed
Close

Summary

Co-secreting TSH and growth hormone pituitary adenomas are rare. We present a case of a 55-year-old woman who presented with symptoms of neck fullness. Ultrasound revealed multiple thyroid nodules and examination revealed several clinical features of acromegaly. She was found to have a co-secreting TSH and growth hormone pituitary macroadenoma. She underwent surgical resection followed by gamma knife radiation, which resulted in complete remission of her TSH and GH-secreting adenoma.

Learning points:

  • TSH-secreting pituitary adenomas are rare and about one-third co-secrete other hormones.

  • Thyroid nodules are common in acromegaly and can be the presenting sign of a growth hormone-secreting pituitary adenoma.

  • In the workup of acromegaly, assessment of other pituitary hormones is essential, even in the absence of symptoms of other pituitary hormone dysfunction.

  • Complete remission of co-secreting GH and TSH pituitary macroadenomas is possible with surgery and radiation alone.

Open access
Mallika Bhat Division of Endocrinology, Department of Medicine

Search for other papers by Mallika Bhat in
Google Scholar
PubMed
Close
,
Matty Mozzor Department of Radiology

Search for other papers by Matty Mozzor in
Google Scholar
PubMed
Close
,
Savneek Chugh Division of Nephrology, New York Medical College, Westchester Medical Center, Valhalla, New York, USA

Search for other papers by Savneek Chugh in
Google Scholar
PubMed
Close
,
Vamsi Buddharaju Division of Nephrology, New York Medical College, Westchester Medical Center, Valhalla, New York, USA

Search for other papers by Vamsi Buddharaju in
Google Scholar
PubMed
Close
,
Monica Schwarcz Division of Endocrinology, Department of Medicine

Search for other papers by Monica Schwarcz in
Google Scholar
PubMed
Close
, and
Guy Valiquette Division of Endocrinology, Department of Medicine

Search for other papers by Guy Valiquette in
Google Scholar
PubMed
Close

Summary

We describe detailed administration of thyroidal and extrathyroidal doses of radioiodine to a patient with end-stage renal disease on hemodialysis. A thorough description of area under curve measurements in a patient with compromised renal function has rarely been described in the literature. Few publications have described thyroid cancer management of patients on hemodialysis, and we believe our management will aid in patient treatment in the future.

Learning points:

  • Scheduling of hemodialysis is important when administering radioactive iodine.

  • Treatment of thyroid cancer with radioiodine in patients with end-stage renal disease requires multidisciplinary approach coordinating dialysis, nuclear medicine and endocrinologists care.

  • Balancing ideal dosage of I131 and the timing of dialysis to insure maximal thyroidal uptake and minimal extra thyroidal I131 concentration is necessary.

Open access
Kursad Unluhizarci Department of Endocrinology

Search for other papers by Kursad Unluhizarci in
Google Scholar
PubMed
Close
,
Hulya Akgun Department of Pathology

Search for other papers by Hulya Akgun in
Google Scholar
PubMed
Close
,
Bahadır Oz Department of Surgery, Erciyes University Medical School, Kayseri, Turkey

Search for other papers by Bahadır Oz in
Google Scholar
PubMed
Close
,
Zuleyha Karaca Department of Endocrinology

Search for other papers by Zuleyha Karaca in
Google Scholar
PubMed
Close
,
Fatih Tanriverdi Department of Endocrinology

Search for other papers by Fatih Tanriverdi in
Google Scholar
PubMed
Close
, and
Fahrettin Kelestimur Department of Endocrinology

Search for other papers by Fahrettin Kelestimur in
Google Scholar
PubMed
Close

Summary

Among various substances produced by C-cells, the most important one is calcitonin (CT) that is used for detection, post-operative follow-up and evaluation of individuals at risk of developing medullary thyroid carcinoma (MTC). However, the role of serum CT measurement in the evaluation of thyroid nodules has been widely discussed, and there is still no consensus about the role of CT in the initial evaluation of all thyroid nodules. Two patients with thyroid nodules whose fine-needle aspiration results were compatible with benign cytology besides having mildly elevated basal serum calcitonin levels were reported. Calcitonin responses (peak levels were 313 and 229 pg/mL, respectively) to calcium stimulation test were compatible with the possible diagnosis of MTC. However, the final diagnosis was papillary thyroid carcinoma of the thyroid gland. There are limited numbers of case reports showing such an increased serum calcitonin responses to calcium stimulation test associated with papillary or follicular thyroid carcinoma of the thyroid. We suggest to measure serum CT level once and in case of normal levels, no further CT measurement is necessary. Physicians should keep in mind that thyroid carcinomas other than MTCs may also be associated with high serum CT levels.

Learning points:

  • Although serum calcitonin is a valuable tumor marker for MTC, it is well known that mild elevations may be seen in some other diseases such as Hashimoto thyroiditis, neuroendocrine tumors or due to medications such as proton pump inhibitors, calcium salts, beta blockers and glucocorticoids.

  • Those two cases indicate that high calcitonin responses to calcium stimulation test, mimicking MTC, may also be seen in patients with papillary thyroid carcinoma although the mechanism is not clear.

Open access
Alex González Bóssolo Endocrinology, Diabetes and Metabolism

Search for other papers by Alex González Bóssolo in
Google Scholar
PubMed
Close
,
Michelle Mangual Garcia Endocrinology

Search for other papers by Michelle Mangual Garcia in
Google Scholar
PubMed
Close
,
Paula Jeffs González Endocrinology, Diabetes and Metabolism, San Juan City Hospital, Hato Rey Pathologies, San Juan, Puerto Rico

Search for other papers by Paula Jeffs González in
Google Scholar
PubMed
Close
,
Miosotis Garcia Endocrinology, Diabetes and Metabolism

Search for other papers by Miosotis Garcia in
Google Scholar
PubMed
Close
,
Guillermo Villarmarzo Endocrinology, Diabetes and Metabolism, San Juan City Hospital, Hato Rey Pathologies, San Juan, Puerto Rico

Search for other papers by Guillermo Villarmarzo in
Google Scholar
PubMed
Close
, and
Jose Hernán Martinez Endocrinology, Diabetes and Metabolism

Search for other papers by Jose Hernán Martinez in
Google Scholar
PubMed
Close

Summary

Classical papillary thyroid microcarcinoma (PTMC) is a variant of papillary thyroid carcinoma (PTC) known to have excellent prognosis. It has a mortality of 0.3%, even in the presence of distance metastasis. The latest American Thyroid Association guidelines state that although lobectomy is acceptable, active surveillance can be considered in the appropriate setting. We present the case of a 37-year-old female with a history of PTMC who underwent surgical management consisting of a total thyroidectomy. Although she has remained disease-free, her quality of life has been greatly affected by the sequelae of this procedure. This case serves as an excellent example of how first-line surgical treatment may result more harmful than the disease itself.

Learning points:

  • Papillary thyroid microcarcinoma (PTMC) has an excellent prognosis with a mortality of less than 1% even with the presence of distant metastases.

  • Active surveillance is a reasonable management approach for appropriately selected patients.

  • Patients should be thoroughly oriented about the risks and benefits of active surveillance vs immediate surgical treatment. This discussion should include the sequelae of surgery and potential impact on quality of life, especially in the younger population.

  • More studies are needed for stratification of PTMC behavior to determine if conservative management is adequate for all patients with this specific disease variant.

Open access
Georgios Velimezis Departments of Surgery

Search for other papers by Georgios Velimezis in
Google Scholar
PubMed
Close
,
Argyrios Ioannidis Departments of Surgery

Search for other papers by Argyrios Ioannidis in
Google Scholar
PubMed
Close
,
Sotirios Apostolakis Departments of Surgery

Search for other papers by Sotirios Apostolakis in
Google Scholar
PubMed
Close
,
Maria Chorti Departments of Surgery

Search for other papers by Maria Chorti in
Google Scholar
PubMed
Close
,
Charalampos Avramidis Departments of Surgery

Search for other papers by Charalampos Avramidis in
Google Scholar
PubMed
Close
, and
Evripidis Papachristou Departments of Surgery

Search for other papers by Evripidis Papachristou in
Google Scholar
PubMed
Close

Summary

During embryogenesis, the thymus and inferior parathyroid glands develop from the third pharyngeal pouch and migrate to their definite position. During this process, several anatomic variations may arise, with the thyroid being one of the most common sites of ectopic implantation for both organs. Here, we report the case of a young female patient, who underwent total thyroidectomy for papillary carcinoma of the thyroid. The patient’s history was remarkable for disorders of the genitourinary system. Histologic examination revealed the presence of well-differentiated intrathyroidal thymic tissue, containing an inferior parathyroid gland. While each individual entity has been well documented, this is one of the few reports in which concurrent presentation is reported. Given the fact that both the thymus and the inferior parathyroid are derivatives of the same embryonic structure (i.e. the third pharyngeal pouch), it is speculated that the present condition resulted from a failure in separation and migration during organogenesis.

Learning points:

  • Intrathyroidal thymus and parathyroid are commonly found individually, but rarely concurrently.

  • It is a benign and asymptomatic condition.

  • Differential diagnosis during routine workup with imaging modalities can be challenging.

Open access
Nicholas Woodhouse Department of Medicine, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman

Search for other papers by Nicholas Woodhouse in
Google Scholar
PubMed
Close
,
Fatima Bahowairath Department of Medicine, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman

Search for other papers by Fatima Bahowairath in
Google Scholar
PubMed
Close
, and
Omayma Elshafie Department of Medicine, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman

Search for other papers by Omayma Elshafie in
Google Scholar
PubMed
Close

Summary

A 55-year-old female was referred with abnormal thyroid function tests (TFTs); the free thyroxine level (FT4) was undetectable <3.3 pmol/L (normal: 7.9–14.4), while her FT3, TSH and urinary iodine levels were normal. She was clinically euthyroid with a large soft lobulated goitre that had been present for more than thirty years. She received an injection of recombinant human TSH (rhTSH) following which there was a progressive rise of the FT3 and TSH levels to 23 pmol/L and >100 mIU/L respectively at 24 h, The FT4 however remained undetectable throughout. Being on thyroxine 100 µg/day for one month, her FT4 level increased to 15 pmol/L and TSH fell to 0.08 mIU/L. Four years earlier at another hospital, her FT4 level had been low (6.8 pmol/L) with a normal TSH and a raised Tc-99 uptake of 20% (normal<4%). We checked the TFTs and Tc-99 scans in 3 of her children; one was completely normal and 2 had euthyroid with soft lobulated goitres. Their Tc-99 scan uptakes were raised at 17% and 15%, with normal TFTs apart from a low FT4 7.2 pmol/L in the son with the largest thyroid nodule. This is a previously unreported form of dyshormonogenesis in which, with time, patients gradually lose their ability to synthesize thyroxine (T4) but not triiodothyroxine (T3).

Learning points:

  • This is a previously unreported form of dyshormonogenetic goitre.

  • This goitre progressively loses its ability to synthesize T4 but not T3.

  • The inability to synthesize T4 was demonstrated by giving rhTSH.

Open access